Summary
Updated Aug 31, 2026
Richard Peters is Director of Aprea Therapeutics, Inc. (APRE). 3 SEC Form 4 filings on record going back to 2025, most recently on 17 June 2026. Lifetime open-market purchases: $100K.
Recent Transactions
2Every recent SEC Form 4 transaction Richard Peters has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Richard Peters go back to 2025: 3 primary Form 4 filings, an average of 1.5 per year. The typical open-market purchase is $50K (2 buys totaling $100K). The largest single buy on record is $100K of APRE in 2026. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Richard Peters files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- John P. Hamill - $30K of APRE open-market activity in the last 12 months
- Oren Gilad - $25K of APRE open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Richard Peters?
Richard Peters is a corporate insider, tracked as Director of Aprea Therapeutics, Inc. (APRE). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Richard Peters submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Richard Peters been buying or selling stock?
Recorded transactions: 2 open-market purchases ($100K) and 0 open-market sales across all tracked filings.
Where can I see all of Richard Peters's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Richard Peters and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial